## PH: Parker-Hannifin Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 1.3% below STRENGTH zone (4.0-10.0%); PEG 4.91 fails VALUE criteria (<1.0); RSI 72 overbought. Stock is in no-man's land without clear edge. Caution: declining volume (55% of avg), momentum weakening (-1.6% MRS), overbought RSI (72).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($838.18)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Parker-Hannifin (PH): Assessing Valuation After Earnings Beat and Strength in Aerospace, Defense and Industrial Demand**
- Source: Simply Wall Street | 20251204T050906 | Bullish | Relevance: 100%
- Parker-Hannifin's stock (PH) jumped after beating earnings and revenue forecasts, driven by strong aerospace, defense, and industrial demand. While a narrative valuation suggests the stock is modestly undervalued by 3.5%, Simply Wall St's DCF model indicates it might be significantly overvalued, raising questions about future growth being fully priced in. The company's shift towards aftermarket and longer-cycle revenue streams is expected to enhance stability and long-term earnings growth.

**2. Parker Hannifin stock reaches all-time high at 869.48 USD By Investing.com**
- Source: Investing.com Nigeria | 20251203T224800 | Bullish | Relevance: 100%
- Parker Hannifin Corporation's stock has hit an all-time high of $869.48, reflecting significant year-to-date and past year growth. This milestone is supported by strong demand, a "GREAT" financial health score, and a 55-year history of consistent dividend payments, alongside a recent major acquisition of Filtration Group Corporation. The company's strategic initiatives and market capitalization efforts continue to boost investor confidence.

**3. Westerkirk Capital Inc. Invests $5.64 Million in Parker-Hannifin Corporation $PH**
- Source: MarketBeat | 20251203T141140 | Bullish | Relevance: 100%
- Westerkirk Capital Inc. has acquired a new stake of 8,070 shares in Parker-Hannifin Corporation (NYSE:PH) worth approximately $5.64 million during the second quarter. This investment comes as Parker-Hannifin reported strong Q3 earnings, beating estimates, and received a consensus "Moderate Buy" rating from analysts with an average price target of $860.71. The company also declared a quarterly dividend of $1.80, while institutional investors show high ownership and some insiders have recently sold shares.

**4. Here's Why You Should Consider Investing in Parker-Hannifin Now**
- Source: Finviz | 20251203T092700 | Bullish | Relevance: 100%
- Parker-Hannifin Corporation (PH) is presented as a strong investment due to its robust Aerospace segment and strategic acquisitions like Filtration Group Corp. and Curtis Instruments. The company's "Win Strategy" and commitment to returning value to shareholders through dividends and buybacks further enhance its investment appeal, with its stock performance already significantly outpacing the industry.

**5. How Strong Aerospace and Defense Growth Will Impact Parker-Hannifin (PH) Investors**
- Source: Simply Wall Street | 20251202T051537 | Bullish | Relevance: 100%
- Parker-Hannifin recently reported strong quarterly results, surpassing analyst expectations, driven by growth in aerospace and defense sectors, and a recovering industrial segment in North America. This performance has led to raised fiscal 2026 guidance, projecting sales growth between 4.0% and 7.0% and higher adjusted EPS, reflecting a positive investment outlook. However, investors are cautioned about potential risks from a sudden aerospace downturn or a slower-than-expected industrial recovery.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 8, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Barclays | $950 | $906 | +5% |
| 2025-11-12 | Baird | $960 | $930 | +3% |
| 2025-11-12 | Susquehanna | $1000 | $960 | +4% |
| 2025-11-10 | Argus Research | $900 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Barclays | main | Overweight |
| 2025-11-12 | Baird | main | Outperform |
| 2025-11-12 | Susquehanna | main | Positive |
| 2025-11-10 | Argus Research | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.00M) |
| Sells | 5 ($3.88M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 8.8% (-0.1%)
- Blackrock Inc.: 7.8% (+0.6%)
- State Street Corpora: 7.6% (-0.7%)
- Procyon Advisors, LL: 4.0% (+158565.8%)
- Bank of America Corp: 3.1% (+0.6%)

### Key Risks

1. Insider selling cluster: $3.9M in recent transactions.
2. Valuation stretched: PEG 4.9x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 8 raises (avg +9%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.91 signals overvaluation risk, limited margin of safety. Forward P/E 26.4x stretched relative to 9% growth. Quality metrics strong (ROE 27%, margin 18%). Analyst sentiment positive (8 raises, avg +9%). Insider selling cluster ($3.9M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $112.4B |
| Beta | 1.25 |
| 52W Range | $488.45 - $908.35 |
| Short Interest | 1.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.91 |
| Forward P/E | 26.4 |
| Current P/E | 28.8 |
| YoY Growth | 9.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.9% to 1.3% (-1.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.7pp (needs >4.0% for momentum thesis). MRS_5 at 0.7% confirms short-term momentum alignment. AM_20 at 3.4% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.06), confirming momentum. RSI overbought at 72, risk of mean reversion. Volume at 55% of 20MA suggests lack of conviction. OFD pattern: +SBL (Volatile).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 1.29% (CS: 63) | Neutral |
| RSI_14 | 72.0 | Overbought |
| MACD Histogram | 1.06 | Bullish |
| vs SMA20 | 1.034x | Above |
| vs SMA50 | 1.105x | Above |
| vs SMA200 | 1.242x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $873.66
- **Stop Loss:** $838.18 (4.1% risk)
- **Target:** $909.14 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 28
- **Position Value:** $24,462.48
- **Portfolio %:** 24.46%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-01-29 (Est: $7.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $6.62 | $7.22 | +9.0% |
| 2025Q2 | $7.08 | $7.69 | +8.6% |
| 2025Q1 | $6.72 | $6.94 | +3.3% |
| 2024Q4 | $6.23 | $6.53 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*